KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of GoodwillAmortization of GoodwillCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)DivestmentsExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Teva Pharmaceutical Industries (TEVA) Cash from Investing Activities (2017 - 2025)

Teva Pharmaceutical Industries' Cash from Investing Activities history spans 9 years, with the latest figure at $165.0 million for Q4 2025.

  • For the quarter ending Q4 2025, Cash from Investing Activities fell 18.32% year-over-year to $165.0 million, compared with a TTM value of $737.0 million through Dec 2025, down 6.94%, and an annual FY2025 reading of $737.0 million, down 6.94% over the prior year.
  • Cash from Investing Activities for Q4 2025 was $165.0 million at Teva Pharmaceutical Industries, up from $135.0 million in the prior quarter.
  • The five-year high for Cash from Investing Activities was $508.0 million in Q1 2021, with the low at $135.0 million in Q3 2025.
  • Average Cash from Investing Activities over 5 years is $233.8 million, with a median of $192.5 million recorded in 2023.
  • Year-over-year, Cash from Investing Activities soared 101.59% in 2021 and then crashed 68.31% in 2022.
  • Tracing TEVA's Cash from Investing Activities over 5 years: stood at $246.0 million in 2021, then plummeted by 31.71% to $168.0 million in 2022, then surged by 79.17% to $301.0 million in 2023, then crashed by 32.89% to $202.0 million in 2024, then dropped by 18.32% to $165.0 million in 2025.
  • Per Business Quant, the three most recent readings for TEVA's Cash from Investing Activities are $165.0 million (Q4 2025), $135.0 million (Q3 2025), and $236.0 million (Q2 2025).